About this approach
Biomarker testing looks for features of a cancer, such as gene changes or proteins, that may help guide treatment. Testing may use tumor tissue, blood or another sample, depending on the question being asked. It can identify an approved treatment option, a clinical trial or a reason a particular drug is unlikely to help. It is a diagnostic tool rather than a treatment. Tumor testing is also different from testing inherited cancer risk, although findings can sometimes overlap.
Where it fits: Established diagnostic tool for selected treatment decisions
Where this treatment is used
The usefulness of testing depends on the cancer, stage, test quality and the decisions it can inform. Some tests evaluate a single established marker; others examine many genes or proteins. A result may identify a well-supported treatment match, a research hypothesis or a change whose significance is uncertain. Not every detected alteration has an effective drug, and a matched drug may still fail to help. Tumors can also change over time, which may make repeat testing relevant. Blood-based testing can be useful in selected situations, but an uninformative result does not always exclude an actionable change. The team should explain which results are clinically established and whether additional tissue or inherited-risk testing is needed.
Procedure and practical considerations
Obtaining tissue can involve pain, bleeding, infection or organ-specific biopsy risks. Testing also brings possible costs, delays and uncertainty, including results that do not change treatment. Some findings may suggest an inherited change that needs separate confirmation and genetic counseling. Avoid changing treatment solely because a commercial report lists a drug; clinical context and the strength of supporting evidence matter.
Clinics reporting this approach
These clinic profiles connect to this approach through clinic-confirmed selections or Cancer Clinic Finder’s source review. Open a profile to compare locations, services, practical details, and ways to get started.
3 connected profiles
Browse all 3 connected profilesSources
Source information checked: 2026-09-29. The links below identify the public and clinic-provided materials used for this page.
- NCI: Biomarker Testing for Cancer Treatment ↗Checked 2026-09-29
- NCI: Tumor Markers ↗Checked 2026-09-29
How Cancer Clinic Finder compiles information · Suggest a factual correction